Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers

Baykara, Meltem; Benekli, Mustafa; EKİNCİ, ÖZGÜR; Irkkan, Sultan; Karaca, Halit; Demirci, Umut; AKINCI, MUHAMMED; Unal, Olcun; Dane, Faysal; Turkoz, Fatma; Balakan, Ozan; Eser, Eylem; Ozturk, Selcuk; ÖZKAN, METİN; Oksuzoglu, Berna; Sevinc, Alper; Demir, Necla; HARPUTLUOĞLU, HAKAN; YALÇIN, BÜLENT; Coskun, UĞUR; ÜNER, AYTUĞ; ÖZET, AHMET; Buyukberber, Suleyman

doi:10.1007/s11605-015-2888-y

Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers

Copy For Citation

Baykara M., Benekli M., EKİNCİ Ö., Irkkan S. C., Karaca H., Demirci U., ...More

JOURNAL OF GASTROINTESTINAL SURGERY, vol.19, no.9, pp.1565-1571, 2015 (SCI-Expanded)

Publication Type: Article / Article
Volume: 19 Issue: 9
Publication Date: 2015
Doi Number: 10.1007/s11605-015-2888-y
Journal Name: JOURNAL OF GASTROINTESTINAL SURGERY
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.1565-1571
Keywords: GC, GEJCs, HER2, Prognosis, C-ERBB-2 PROTEIN EXPRESSION, C-ERB B-2, PROGNOSTIC-SIGNIFICANCE, GENE AMPLIFICATION, CLINICOPATHOLOGICAL FEATURES, GROWTH, TRASTUZUMAB, CARCINOMAS, SURVIVAL, ADENOCARCINOMA
Gazi University Affiliated: Yes

Abstract

In this study, we investigated the rate of human epidermal growth factor receptor 2 (HER2) overexpression in gastric (GC) and gastroesophageal junction cancers (GEJCs) and the relationship with HER2 expression and clinical, pathological parameters and prognosis.